Financial results for the period ended September 30, 2026
As filed · Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
EarningsNotablemateriality 70 out of 100
What happened
FactFinancial results for the period ended September 30, 2026. Press Release on Unaudited Financial Results of the Company for the quarter and half-year ended. Unaudited Consolidated Financial Results of the Company for the quarter and half-year ended.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
WithdrawnEarlierQ1 FY27
So, altogether, right now, we are targeting 27.
NowQ1 FY27
It should be in the range of tens of millions of dollars, that specific launch.
Change
FactGuidance withdrawn
Implication
CapitSignal interpretationThe earlier statement indicated a specific target of 27, while the current statement no longer provides a specific target, instead referring to a range of tens of millions of dollars.confidence 90%
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- I believe, 100 plus of million dollars coming to us as a growth in the next 2 to 3 years from that. (management committed by H1 FY28)
- So, altogether, right now, we are targeting 27. (management committed by FY27)
Evidence
- Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q3 FY26
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%